Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R John Collier

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Molecular and Cellular Biology|June 21, 2005
Membrane insertion by anthrax protective antigen in cultured cellsMaen Qa'dan, Kenneth A Christensen, Lei Zhang, et al.
Biochemical and Biophysical Research Communications|August 18, 2004
Anthrax toxin complexes: heptameric protective antigen can bind lethal factor and edema factor simultaneouslyRuth-Anne L Pimental, Kenneth A Christensen, Bryan A Krantz, et al.
Infection and Immunity|July 20, 2007
Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxinStephen J Juris, Roman A Melnyk, Robert E Bolcome, et al.
Journal of Molecular Biology|November 10, 2004
Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxinBryan A Krantz, Amar D Trivedi, Kristina Cunningham, et al.
Biochemistry|July 19, 2008
Amino acid residues involved in membrane insertion and pore formation of Clostridium botulinum C2 toxinAlexander E Lang, Tobias Neumeyer, Jianjun Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formationD Borden Lacy, Darran J Wigelsworth, Roman A Melnyk, et al.
Infection and Immunity|May 24, 2005
Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccinesBenedikt A Aulinger, Michael H Roehrl, John J Mekalanos, et al.
Cellular Microbiology|May 5, 2010
Imaging the cell entry of the anthrax oedema and lethal toxins with fluorescent protein chimerasIrene Zornetta, Lucia Brandi, Blythe Janowiak, et al.
Protein Science : a Publication of the Protein Society|July 18, 2009
Solubilization and characterization of the anthrax toxin pore in detergent micellesGregory Vernier, Jie Wang, Laura D Jennings, et al.
The Journal of Biological Chemistry|October 27, 2004
Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling studyKyoung Joon Oh, Scott Barbuto, Natalie Meyer, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Biology|June 21, 2005
Membrane insertion by anthrax protective antigen in cultured cellsMaen Qa'dan, Kenneth A Christensen, Lei Zhang, et al.
Biochemical and Biophysical Research Communications|August 18, 2004
Anthrax toxin complexes: heptameric protective antigen can bind lethal factor and edema factor simultaneouslyRuth-Anne L Pimental, Kenneth A Christensen, Bryan A Krantz, et al.
Infection and Immunity|July 20, 2007
Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxinStephen J Juris, Roman A Melnyk, Robert E Bolcome, et al.
Journal of Molecular Biology|November 10, 2004
Acid-induced unfolding of the amino-terminal domains of the lethal and edema factors of anthrax toxinBryan A Krantz, Amar D Trivedi, Kristina Cunningham, et al.
Biochemistry|July 19, 2008
Amino acid residues involved in membrane insertion and pore formation of Clostridium botulinum C2 toxinAlexander E Lang, Tobias Neumeyer, Jianjun Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2004
Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formationD Borden Lacy, Darran J Wigelsworth, Roman A Melnyk, et al.
Infection and Immunity|May 24, 2005
Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccinesBenedikt A Aulinger, Michael H Roehrl, John J Mekalanos, et al.
Cellular Microbiology|May 5, 2010
Imaging the cell entry of the anthrax oedema and lethal toxins with fluorescent protein chimerasIrene Zornetta, Lucia Brandi, Blythe Janowiak, et al.
Protein Science : a Publication of the Protein Society|July 18, 2009
Solubilization and characterization of the anthrax toxin pore in detergent micellesGregory Vernier, Jie Wang, Laura D Jennings, et al.
The Journal of Biological Chemistry|October 27, 2004
Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling studyKyoung Joon Oh, Scott Barbuto, Natalie Meyer, et al.
Pageof 8